Inflammatory Arthritis Beyond the Joints

Comorbidities and other Manifestations

1 Edición, Volumen 18 - 17 de abril de 2026
Última edición
Editores: Fabiola Atzeni, Elena Nikiphorou
Idioma: Inglés

Inflammatory Arthritis Beyond the Joints, Volume 18 in Elsevier’s Handbook for Systemic Autoimmune Diseases series, provides an extensive review of the most recent research on var… Leer más

Descripción

Inflammatory Arthritis Beyond the Joints, Volume 18 in Elsevier’s Handbook for Systemic Autoimmune Diseases series, provides an extensive review of the most recent research on various comorbidities and EAMs associated with inflammatory arthritis. The book emphasizes early detection, which is crucial for improving patient quality of life and survivability outcomes, as many adults with inflammatory arthritis also suffer from other chronic conditions. The book's chapters cover comorbidities and EAMs in both early and late disease stages.

They delve into the mechanisms behind the development of these conditions and examine the impact of new treatment strategies specific to inflammatory arthritis and related diseases, including cardiovascular disease, metabolic syndrome, metabolic bone disease, infection, neoplasia, respiratory disease, gastrointestinal disorders, kidney issues, mental health conditions, and neurological diseases. This book serves as a valuable reference for researchers and clinicians focused on inflammatory arthritis and its associated conditions.

Puntos claves

Includes a comprehensive review of different comorbidities and extra-articular/extramusculoskeletal manifestations in inflammatory arthritis
Discusses the impact of comorbidities and other manifestations on outcomes in inflammatory arthritis
Highlights current and new targeted therapies for the treatment of inflammatory arthritis

De interès para

Immunologists, rheumatologists, hematologists, cardiologists, post graduate students and those working in autoimmune diseases, general medicine, and hospital/pharmaceutical management Medical/scientific management and pharmaceutical companies

Índice

1. Introduction to comorbidities, extra-articular and extra-musculoskeletal manifestations

2. Cardiovascular disease and rheumatoid arthritis

3. Cardiovascular disease and spondyloarthritis

4. Cardiovascular disease and psoriatic arthritis

5. Metabolic syndrome and psoriatic arthritis

6. Bone involvement in rheumatoid arthritis, spondyloarthritis and psoriatic arthritis

7. Infection and rheumatoid arthritis, spondyloarthritis and psoriatic arthritis

8. Pulmonary manifestations in rheumatoid arthritis

9. Gastrointestinal involvement in spondyloarthritis

10. Mental health disorders in rheumatoid arthritis, spondyloarthritis and psoriatic arthritis

11. Alzheimer’s disease and rheumatoid arthritis

Detalles del producto

Edición: 1
Última edición
Volumen: 18
Publicado: 20 de abril de 2026
Idioma: Inglés

Sobre los editores

Fabiola Atzeni

Fabiola Atzeni, MD, PhD is currently Full Professor and Head of the Rheumatology Unit, University of Messina, Messina, Italy. Her clinical and research interest lies in immunotherapies in autoimmune diseases with particular focus on the investigation and management of differential response to biological therapies in rheumatoid arthritis (RA) and Spondyloarthritis (SpA), and cardiovascular aspects of the different rheumatic diseases with particular emphasis on arteriosclerosis. Dr. Atzeni has co-authored over 400 publications in peer-reviewed journals and several book chapters, is a regular reviewer for several international journals. She is involved in several international and national meetings focused on cardiovascular and infection aspects.

Afiliaciones y experiencia

Full Professor and Head of Rheumatology Unit, University of Messina, Messina, Italy

Elena Nikiphorou

Elena Nikiphorou, MD, PhD, is an Adjunct Senior Lecturer at King’s College London and Consultant Rheumatologist at King’s College Hospital in London, United Kingdom. She has a clinical and academic interest in inflammatory arthritis and the role of multi-morbidity and long-term outcomes of disease. She has been the recipient of multiple awards, bursaries, and competitive roles, and has held key leadership positions at national and international levels.